Genmab

-$0.34 (-1.02%) As of 11:05 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genmab and other ETFs, options, and stocks.

About GMAB

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases.

CEO
Jan G. J. van de Winkel
Employees
1,212
Headquarters
Copenhagen, Capital Region
Founded
1998

GMAB Key Statistics

Market cap
21.82B
Price-Earnings ratio
58.73
Dividend yield
—
Average volume
447.74K
High today
$33.45
Low today
$32.97
Open price
$33.05
Volume
567.64K
52 Week high
$49.07
52 Week low
$26.19

GMAB Earnings

$0.00
$0.39
$0.78
$1.17
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Available Aug 10
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure